14
June

08:00 AM BST

Oncology

Strategy Meeting Europe 2022

The premier meeting for European Oncology professionals

Radisson Blu Hotel, Stansted Airport

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Oncology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Oncology professionals from across Europe, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Become an official strategy meeting partner

Whatever your business needs, we can help. Get in touch for partnering opportunities

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Meet Our 2022 Speakers

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our 2022 Oncology strategy meeting.

Krystyna Nahlik, PhD

Senior Field Application Scientist Clinical Genomics LGC Clinical Diagnostics

Claudia Hesselmann, PhD

Co-founder & CEO ARENSIA

Mike Reed, PhD

Chief Scientist, PhysioPD Rosa & Co.

Dr. Reed brings 15 years of experience managing large-scale strategic collaborations with client biopharmaceutical and consumer product organizations.
At Rosa (and previously at Entelos, Inc.), his areas of expertise include metabolic diseases, oncology, central nervous system diseases, and inflammation/immunology. His efforts focus on trial design, target evaluation, competitive differentiation, and novel biomarkers, and have led to several patents and publications. Dr. Reed’s work has been presented at dozens of scientific conferences worldwide.
Prior to his position at Entelos, Dr. Reed held positions in preclinical pharmacology and drug development at Shaman Pharmaceuticals Inc. and Tularik Inc. (acquired by Amgen Inc.). His contributions include the development of novel animal models for type 2 diabetes.
Dr. Reed completed his BS in Biology and MA in Exercise Physiology at The University of Texas at Austin, and a PhD in Exercise Physiology at The Ohio State University. He completed his postdoctoral fellowship at Stanford University, which focused on the mechanistic evaluation of insulin resistance in animal models.

Barnaby Balmforth, PhD

Chief Executive Officer Biofidelity

Mahendra Deonarain

CEO Antikor Biopharma

Hani Gabra

Co-founder and CSO Papyrus Therapeutics

Oliver Nussbaumer

VP Immunology GammaDelta Therapeutics / Takeda

Oliver Nussbaumer is an entrepreneur and scientific leader in the field of immunotherapy and founder of Gammadelta Therapeutics and Adaptate Biotherapeutics. Oliver has over 10 years proven track record in translational R&D, early process development and team building/leading teams in the field of immuno-oncology cell therapy. Having published multiple papers on the biology, potential and translation of human γδ T-cells, Oliver’s research enabled pioneering methods to isolate, expand and study human tissue resident γδ T-cells for clinical use, leading to over 10 international patent applications. In the past, Oliver’s work was supported by the Medical Research Council and recognised with Industry awards by Sanofi, the Austrian Ministry of Science and the Austrian Society of Immunology. Oliver joined GammaDelta Therapeutics full-time shortly after its incorporation as Head of Cell Research, responsible for process development. In early 2020, he was appointed as Vice President, Immunology and is now leading on early process development as well as research and discovery.

Sonal Patel

VP, Oncology Scientific Innovation Johnson & Johnson

Sonal joined Johnson & Johnson Innovation, London in 2016. As VP of Oncology Scientific Innovation, EMEA her role is to identify and champion the execution of transformative scientific opportunities for Janssen oncology. Before joining the Johnson and Johnson family, Sonal was Senior Director of External Innovation at Roche in Basel, Switzerland. She also was Head of Disease Biology in the Bioelectronic Medicines R&D unit of Glaxo SmithKline in Stevenage, UK. In both roles Sonal Led scientific diligence of new opportunities across therapeutic modalities including devices and led partnerships to develop a portfolio of external collaborations for pharma.
Sonal has had an extensive prior career in biotech in the UK as Head of Molecular Pharmacology at Prosidion-OSI, at a start-up company, Piramed on small molecule discovery for PI3K family and at Oxford Glycosciences, a proteomics platform company, leading target Identification and validation for oncology discovery projects. 
Sonal completed postdoctoral training at the Lombardi Cancer Centre, Dept. of Radiation Medicine at Georgetown University

Nahuel Villegas

Chief Scientific Officer Vivan Therapeutics

Mihriban Tuna

Chief Scientific Officer Adaptate Biotherapeutics / Takeda

Achim Kaunert

Senior Manager Business Development Central Europe Personalis

Mark Thornber

Associate Director, Biopharma Business Development Personalis

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

Achim Kaunert

Senior Manager Business Development Central Europe Personalis

Mark Thornber

Associate Director, Biopharma Business Development Personalis

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

14 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting East Coast USA 2024

21 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting West Coast USA 2024

22 Oct 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024

11 Nov 2024

Bioinformatics and IT Strategy Meeting East Coast USA 2024

16 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

23 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting West Coast USA 2024

14 Nov 2024

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

12 Nov 2024

Drug Discovery Biology Strategy Meeting East Coast USA 2024

15 May 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

22 May 2024

Medicinal Chemistry Strategy Meeting West Coast USA 2024

23 Oct 2024

Medicinal Chemistry Strategy Meeting Europe 2024

13 Nov 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Europe

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024

Oncology

Strategy Meeting Europe 2022

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Radisson Blu Hotel, Stansted Airport

Fresh Oncology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Become an official strategy meeting partner

Press play to hear what your colleagues had to say...

See the full agenda and facilitator line-up

Meet Our 2022 Speakers

Krystyna Nahlik, PhD

Claudia Hesselmann, PhD

Mike Reed, PhD

Barnaby Balmforth, PhD

Mahendra Deonarain

Hani Gabra

Oliver Nussbaumer

Sonal Patel

Nahuel Villegas

Mihriban Tuna

Achim Kaunert

Mark Thornber

Govinda Bhisetti

Achim Kaunert

Mark Thornber

Our 2022 Thought Leader

Our 2022 Co-Hosts

Want to find out more?

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

14
May
2024

21
May
2024

22
Oct
2024

11
Nov
2024

16
May
2024

23
May
2024

14
Nov
2024

12
Nov
2024

15
May
2024

22
May
2024

23
Oct
2024

13
Nov
2024

Radisson Blu Hotel, Stansted Airport